InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by Babu Yarlagadda S, Officier. Officer active across 1 companies, notably Biocryst Pharmaceuticals INC. In total, 5 filings have been published. Total volume traded: €316k. The latest transaction was filed on 7 March 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€315,60020,000 shares@ €15.780.019% mcap37.8% of flow
Common Stock
SEC:0001127602-22-008780:0·
035,000 shares0
Common Stock
SEC:0001127602-21-031134·
035,000 shares0
Common Stock
SEC:0001127602-21-031134:0·
€259,82862,000 shares@ €4.19080.016% mcap100.0% of flow
Common Stock
SEC:0001127602-21-030610·
€259,82862,000 shares@ €4.19080.016% mcap31.1% of flow
Common Stock
SEC:0001127602-21-030610:0·
5 of 5 declarations
About Babu Yarlagadda S
S. Babu Yarlagadda is Chief Discovery Officer at Biocryst Pharmaceuticals Inc. In this role, he oversees research and development activities, contributing to innovation in the pharmaceutical field. Yarlagadda plays a key role in the strategy for developing new drugs.
